Investigating the Safety and Performance of Two New 1-piece Ostomy Products Compared With SenSura 1-piece
Not Applicable
Completed
- Conditions
- Ileostomy - Stoma
- Registration Number
- NCT01957488
- Lead Sponsor
- Coloplast A/S
- Brief Summary
The aim of the current investigation is to investigate the performance of two new 1-piece ostomy products
- Detailed Description
The present investigation aims at testing the performance and safety of the two new 1-piece ostomy products
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 183
Inclusion Criteria
- Have given written informed consent and signed letter of authority (mandatory in DK)
- Be at least 18 years of age and have full legal capacity.
- Be able to handle the products themselves
- Have an ileostomy with a diameter between 10 and 40 mm.
- Have had their ostomy for at least three months.
- Have within the last month used a 1-piece flat product with open bag
- Currently using midi or maxi bags
- Willing to use minimum 1 product every second day, i.e. maximum 2 days wear time.
- Be suitable for participation in the investigation
- Must be able to use custom cut product
- Negative result of a pregnancy test for women of childbearing age (only DK)
Exclusion Criteria
- Currently receiving or have within the past 2 months received radio- and/or chemotherapy.
- Currently receiving or have within the past month received systemic steroid or local treatment in the peristomal area
- Are pregnant or breastfeeding
- Participating in other interventional clinical investigations or have previously participated in this investigation
- Has participated in the previous explorative Coloplast studies CP236 and CP237
- Are currently or during the study using ostomy belt
- Has a stoma below skin surface
- Currently suffering from peristomal skin problems (i.e.bleeding and/or broken skin)
- Has known hypersensitivity towards any of the test products
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Leakage 14 +- 1 days The fraction of baseplates with No leakage/seeping under the baseplate was measured. Leakage/seeping under the baseplate was assessed after each baseplate change.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
Holtedam 3
🇩🇰Humlebæk, Denmark
QPS Nederlands
🇳🇱Groningen, Netherlands
Sykepleierklinikken
🇳🇴Larvik, Norway
Synexus Limited
🇬🇧Chorley, Lancashire, United Kingdom
Holtedam 3🇩🇰Humlebæk, Denmark